SageView Advisory Group’s Alignment Healthcare ALHC Stock Holding History

SageView Advisory Group’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.82K	Buy	+92	New	+$1.65K	﹤0.01%	2264

Other funds holding ALHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SageView Advisory Group's ALHC Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Alignment Healthcare (ALHC) in Q4 2025: 92 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #2264 among its holdings.

263 funds tracked by Wall St. Rank hold ALHC as of Q4 2025.

SageView Advisory Group held 92 shares of Alignment Healthcare worth $1.82K as of Q4 2025.
Alignment Healthcare was a new SageView Advisory Group position in Q4 2025.
Alignment Healthcare made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2264 holding.
263 funds tracked by Wall St. Rank held Alignment Healthcare as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.